HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES

Zacks Equity Research
Zacks Rank can tell you which stocks to buy and sell. Zacks Equity Research tells you why. Click here to learn more.
Quote:
Login Free Membership
Search:

 
Growth & Income

Steris Corporation

February 05, 2009 | Comments: 0
Recommended this article (0)
STE
Print    Share
Steris Corporation (STE - Snapshot Report) recently posted solid fiscal third-quarter results. Revenues jumped 2% year-over-year, while net income of $28.6 million topped the year-prior $21.8 million.

Company Description

Steris Corporation provides infection prevention and surgical products and services to the healthcare and pharmaceutical industries.

The Company employs more than 5,000 employees around the world with the mission of providing a healthier today and a safer tomorrow through knowledgeable people and innovative infection prevention, decontamination and health science technologies, products and services.

Quarterly results Reflect Growth

Steris recently posted solid fiscal third-quarter results. Revenues jumped 2% year-over-year, while net income of $28.6 million topped the year-prior $21.8 million.

Excluding charges, earnings per share totaled 53 cents, compared to the previous year’s 35 cents.

Management stated that, as the case with many of its industry peers, STE saw the impact of the broader economic issues affecting its top-line performance in the third quarter. In particular, within the company’s Healthcare segment, sales for infection control related capital equipment saw a slowdown. However, STE’s surgical products showed strong growth in the quarter, driven by new products.

President and chief executive officer Walt Rosebrough said, "substantial growth in profitability was driven by the fine work of our people to improve our efficiencies in conjunction with acceptance of our new products by our customers. We now believe that fiscal 2009 revenue growth will be approximately 4%, while earnings will be toward the high end of our range of $1.65 - $1.80."

Upbeat Forecasts

Analysts are calling for earnings of $1.77 per share for the year ending March 2009, which is up from last month’s $1.76.

For the following year, analysts are forecasting $1.83 per share, versus last month’s $1.62.

The company’s earnings per share are expected to grow about 15% over the next 3 – 5 years, which is in line with the industry average.

Competitive Payouts

Steris pays an annual dividend of 32 cents per share, which translates into a dividend yield of 1.2%.

The income shareholders receive from STE is well above the industry average as most of the company’s peers pay no dividends.


Email

Print

Share

RSS

Rate Pos

Rate Neg

Comment
Read/Post Comments (0) | Recommended this article (0)
 Posting Comment...
There was a problem posting this this comment. Please try back later.
[CLICK TO CLOSE X]
Comments (Limit 1000 Characters - Used: 0)
Display Name: Email Address:  
 Loading Comments...
Be the first to comment on this article!

More Zacks Resources

Market Summary Nov 23, 2009 14:37 pm ET
DJIA 10453.67  135.51 1.31%
NASD 2174.84  28.80 1.34%
S&P 500 1106.18  14.80 1.36%
Sponsored Links